Gene editing: Navigating IP, deal-making and regulatory challenges
James Fry
Head of Life Sciences
Mills & Reeve LLP
Michael Arciero
Vice President IP & Commercial Development
ERS Genomics
Mike Ward
Global Head of Life Sciences & Healthcare Thought Leadership
Clarivate
Dr. Tobias Brambrink
J.D. VP, Intellectual Property
Clarivate
